Trials / Completed
CompletedNCT01327118
Prostaglandin F2alpha in a Human Headache Model
Headache Inducing Characteristics and Possible Changes in Cerebral Blood Flow After Administration of Prostaglandin F2alpha
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 12 (estimated)
- Sponsor
- Danish Headache Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
The hypothesis of this study is that PGF2alpha does not induce headache or dilatation of brain vessels.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Prostaglandin F2alpha | intravenous injection |
| DRUG | Isoton sodium chloride | intravenous injection |
Timeline
- Start date
- 2010-09-01
- Primary completion
- 2010-12-01
- Completion
- 2010-12-01
- First posted
- 2011-04-01
- Last updated
- 2011-04-14
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT01327118. Inclusion in this directory is not an endorsement.